Your browser doesn't support javascript.
loading
Effect of genetic polymorphisms on outcomes following nivolumab for advanced renal cell carcinoma in the SNiP-RCC trial.
Shiota, Masaki; Miyake, Hideaki; Takahashi, Masayuki; Oya, Mototsugu; Tsuchiya, Norihiko; Masumori, Naoya; Matsuyama, Hideyasu; Obara, Wataru; Shinohara, Nobuo; Fujimoto, Kiyohide; Nozawa, Masahiro; Ohba, Kojiro; Ohyama, Chikara; Hashine, Katsuyoshi; Akamatsu, Shusuke; Kamba, Tomomi; Mita, Koji; Gotoh, Momokazu; Tatarano, Shuichi; Fujisawa, Masato; Tomita, Yoshihiko; Mukai, Shoichiro; Ito, Keiichi; Tanegashima, Tokiyoshi; Tokunaga, Shoji; Eto, Masatoshi.
Affiliation
  • Shiota M; Department of Urology, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka, 812-8582, Japan. shiota.masaki.101@m.kyushu-u.ac.jp.
  • Miyake H; Department of Urology, Hamamatsu University School of Medicine, Hamamatsu, Japan.
  • Takahashi M; Department of Urology, Tokushima University Graduate School of Biomedical Sciences, Tokushima, Japan.
  • Oya M; Department of Urology, Keio University School of Medicine, Tokyo, Japan.
  • Tsuchiya N; Department of Urology, Faculty of Medicine, Yamagata University, Yamagata, Japan.
  • Masumori N; Department of Urology, Sapporo Medical University School of Medicine, Sapporo, Japan.
  • Matsuyama H; Department of Urology, Graduate School of Medicine, Yamaguchi University, Ube, Japan.
  • Obara W; Department of Urology, Iwate Medical University School of Medicine, Iwate, Japan.
  • Shinohara N; Department of Renal and Genitourinary Surgery, Hokkaido University Graduate School of Medicine, Sapporo, Japan.
  • Fujimoto K; Department of Urology, Nara Medical University, Kashihara, Japan.
  • Nozawa M; Department of Urology, Faculty of Medicine, Kindai University, Osaka, Japan.
  • Ohba K; Department of Urology, Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki, Japan.
  • Ohyama C; Department of Urology, Hirosaki University Graduate School of Medicine, Hirosaki, Japan.
  • Hashine K; Department of Urology, National Hospital Organization Shikoku Cancer Center, Matsuyama, Ehime, Japan.
  • Akamatsu S; Department of Urology, Kyoto University Graduate School of Medicine, Kyoto, Japan.
  • Kamba T; Department of Urology, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan.
  • Mita K; Department of Urology, Hiroshima City Asa Citizens Hospital, Hiroshima, Japan.
  • Gotoh M; Department of Urology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
  • Tatarano S; Department of Urology, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima, Japan.
  • Fujisawa M; Department of Urology, Kobe University Graduate School of Medicine, Kobe, Japan.
  • Tomita Y; Department of Urology and Molecular Oncology, Graduate School of Medicine and Dental Sciences, Niigata University, Niigata, Japan.
  • Mukai S; Department of Urology, Faculty of Medicine, University of Miyazaki, Miyazaki, Japan.
  • Ito K; Department of Urology, National Defense Medical College, Saitama, Japan.
  • Tanegashima T; Department of Urology, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka, 812-8582, Japan.
  • Tokunaga S; Medical Information Center, Kyushu University Hospital, Fukuoka, Japan.
  • Eto M; Department of Urology, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka, 812-8582, Japan.
Cancer Immunol Immunother ; 72(6): 1903-1915, 2023 Jun.
Article in En | MEDLINE | ID: mdl-36729213

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Renal Cell / Kidney Neoplasms Type of study: Guideline / Prognostic_studies Limits: Humans Language: En Journal: Cancer Immunol Immunother Journal subject: ALERGIA E IMUNOLOGIA / NEOPLASIAS / TERAPEUTICA Year: 2023 Document type: Article Affiliation country: Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Renal Cell / Kidney Neoplasms Type of study: Guideline / Prognostic_studies Limits: Humans Language: En Journal: Cancer Immunol Immunother Journal subject: ALERGIA E IMUNOLOGIA / NEOPLASIAS / TERAPEUTICA Year: 2023 Document type: Article Affiliation country: Country of publication: